380 Results

People

  1. Levine
    Levine
  2. Ladanyi
    Ladanyi
  3. Schultz
    Schultz
  4. Chan
    Chan
  5. Patel
    Patel
  6. Abdel-Wahab
    Abdel-Wahab
  7. Shen
    Shen
  8. Sander
    Sander
  9. Benhamida
    Benhamida
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. GSK Faculty (188)
  2. Department of Medicine (102)
  3. Sloan Kettering Institute Postdocs (89)
  4. Department of Pathology and Laboratory Medicine (87)
  5. Human Oncology and Pathogenesis Program (76)
  6. Sloan Kettering Institute Faculty (75)
  7. Tow Center for Developmental Oncology (TCDO) (71)
  8. Center for Hematologic Malignancies (70)
  9. Hematologic Malignancies, Division of (60)
  10. Surgery (60)
  1. "dna methylation"
Formats
  1. Journal Article (355)
  2. Review (12)
  3. Editorial (7)
  4. Research Letter (5)
  5. Correspondence (1)
Groups
  1. GSK Faculty (188)
  2. Department of Medicine (102)
  3. Sloan Kettering Institute Postdocs (89)
  4. Department of Pathology and Laboratory Medicine (87)
  5. Human Oncology and Pathogenesis Program (76)
  6. Sloan Kettering Institute Faculty (75)

More Groups

People
  1. Ross Levine (25)
  2. Marc Ladanyi (24)
  3. Nikolaus Schultz (18)
  4. Dinshaw Patel (17)
  5. Timothy Chan (17)
  6. Omar Abdel-Wahab (16)

More People

Years
  1. 2025 (12)
  2. 2024 (25)
  3. 2023 (22)
  4. 2022 (20)
  5. 2021 (15)
  6. 2020 (15)

More Years

Publications
  1. Nature (24)
  2. Cancer Research (11)
  3. Cell (11)
  4. Cancer Cell (9)
  5. Cell Reports (9)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Nature Publishing Group (71)
  2. Cell Press (46)
  3. American Association for Cancer Research (27)
  4. Elsevier Inc. (17)
  5. Oxford University Press (16)
  6. Springer (16)

More Publishers

Results (380)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • LKB1 inactivation promotes epigenetic remodeling-induced lineage plasticity and antiandrogen resistance in prostate cancer
    Journal Article

    Li, F.; Dai, P.; Shi, H.; Zhang, Y.; He, J.; Gopalan, A.; Li, D.; Chen, Y.; Du, Y.; Xu, G.; more...
    Cell Research (2025)

    Fulltext@MSK | Save
  • Ageing limits stemness and tumorigenesis by reprogramming iron homeostasis
    Journal Article

    Zhuang, X.; Wang, Q.; Joost, S.; Ferrena, A.; Humphreys, D. T.; Li, Z.; Blum, M.; Krause, K.; Ding, S.; Landais, Y.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • Translational aspects of epithelioid sarcoma: Current consensus
    Review

    Grünewald, T. G. P.; Postel-Vinay, S.; Nakayama, R. T.; Berlow, N. E.; Bolzicco, A.; Cerullo, V.; Dermawan, J. K.; Frezza, A. M.; Italiano, A.; Jin, J. X.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • DNA methylation classes of stage II and III primary melanomas and their clinical and prognostic significance
    Journal Article

    Conway, K.; Edmiston, S. N.; Vondras, A.; Reiner, A.; Corcoran, D. L.; Shen, R.; Parrish, E. A.; Hao, H.; Lin, L.; Kenney, J. M.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sites
    Journal Article

    Calina, T. G.; Perez, E.; Grafenhorst, E.; Benhamida, J.; Schallenberg, S.; Popescu, A.; Koch, I.; Janik, T.; Chen, B.; Ihlow, J.; more...
    Clinical Epigenetics (2024)

    Fulltext@MSK | Save
  • The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
    Review

    van den Bent, M. J.; French, P. J.; Brat, D.; Tonn, J. C.; Touat, M.; Ellingson, B. M.; Young, R. J.; Pallud, J.; von Deimling, A.; Sahm, F.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas
    Journal Article

    Fischer, A.; Albert, T. K.; Moreno, N.; Interlandi, M.; Mormann, J.; Glaser, S.; Patil, P.; de Faria, F. W.; Richter, M.; Verma, A.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Expanding the clinicopathologic spectrum and genomic landscape of tumors with SMARCA2/4::CREM fusions
    Journal Article

    Cyrta, J.; Dermawan, J. K.; Tauziède-Espariat, A.; Liu, T.; Rosenblum, M.; Shroff, S.; Katabi, N.; Cardoen, L.; Guillemot, D.; Masliah-Planchon, J.; more...
    Journal of Pathology (2024)

    Fulltext@MSK | Save
  • Epigenetic therapy in a rare ovarian cancer - A double-edged sword
    Correspondence

    Hsu, C.; Konner, J. A.; Gounder, M. M.
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
    Research Letter

    Connor, M. P.; Prathapa, N.; Frey, N. V.; Gill, S. I.; Hexner, E. O.; Bruno, X. J.; Lai, C. E.; Loren, A. W.; Luger, S. M.; Matthews, A. H.; more...
    Haematologica (2024)

    Fulltext@MSK | Save